APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nitinol-based Medical Device

Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc.

Selected research

Market Outlook & Growth Opportunities

Global Nitinol-based Medical Device Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchNitinol-based Medical Device Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitinol-based Medical Device Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Nitinol-based Medical Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitinol-based Medical Device Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitinol-based Medical Device Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc.

Global Nitinol-based Medical Device key players include Abbott, Medtronic, Boston Scientific, TERUMO, BD, etc. Global top five manufacturers hold a share over 85%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

Read the full market overview

In terms of product, Guidewires is the largest segment, with a share over 45%. And in terms of application, the largest application is Vascular, followed by Orthopedic and Dental, etc.

This report provides an overview of the global Nitinol-based Medical Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nitinol-based Medical Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nitinol-based Medical Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nitinol-based Medical Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Nitinol-based Medical Device Segment by Company

Medtronic

Edwards Lifesciences

Abbott

Boston Scientific

TERUMO

BD

Cordis

Cook Medical

B. Braun

Biotronik

Stryker

JOTEC

MicroPort

Acandis

ELLA-CS

Nitinol-based Medical Device Segment by Type

Stents

Guidewires

Others

Nitinol-based Medical Device Segment by Application

Vascular

Orthopedic and Dental

Others

Nitinol-based Medical Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nitinol-based Medical Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nitinol-based Medical Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nitinol-based Medical Device significant trends, drivers, influence factors in global and regions.

6. To analyze Nitinol-based Medical Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol-based Medical Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitinol-based Medical Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol-based Medical Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nitinol-based Medical Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nitinol-based Medical Device industry.

Chapter 3: Detailed analysis of Nitinol-based Medical Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nitinol-based Medical Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nitinol-based Medical Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nitinol-based Medical Device Industry Trends Table 2. Nitinol-based Medical Device Industry Drivers Table 3. Nitinol-based Medical Device Industry Opportunities and Challenges Table 4. Nitinol-based Medical Device Industry Restraints Table 5. Global Nitinol-based Medical Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nitinol-based Medical Device Revenue Share by Company (2021-2026) Table 7. Global Nitinol-based Medical Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nitinol-based Medical Device Sales Volume Share by Company (2021-2026) Table 9. Global Nitinol-based Medical Device Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Nitinol-based Medical Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nitinol-based Medical Device Key Company Manufacturing Base & Headquarters Table 12. Global Nitinol-based Medical Device Company, Product Type & Application Table 13. Global Nitinol-based Medical Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nitinol-based Medical Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Stents Table 18. Significant Companies of Guidewires Table 19. Significant Companies of Others Table 20. Global Nitinol-based Medical Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Nitinol-based Medical Device Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Nitinol-based Medical Device Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Nitinol-based Medical Device Sales Volume Share by Type (2021-2026) Table 24. Global Nitinol-based Medical Device Sales Volume Share by Type (2027-2032) Table 25. Global Nitinol-based Medical Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nitinol-based Medical Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nitinol-based Medical Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nitinol-based Medical Device Sales Value Share by Type (2021-2026) Table 29. Global Nitinol-based Medical Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Vascular Table 31. Significant Companies of Orthopedic and Dental Table 32. Significant Companies of Others Table 33. Global Nitinol-based Medical Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Nitinol-based Medical Device Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Nitinol-based Medical Device Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Nitinol-based Medical Device Sales Volume Share by Application (2021-2026) Table 37. Global Nitinol-based Medical Device Sales Volume Share by Application (2027-2032) Table 38. Global Nitinol-based Medical Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Nitinol-based Medical Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Nitinol-based Medical Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Nitinol-based Medical Device Sales Value Share by Application (2021-2026) Table 42. Global Nitinol-based Medical Device Sales Value Share by Application (2027-2032) Table 43. Global Nitinol-based Medical Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Nitinol-based Medical Device Sales by Region (2021-2026) & (K Units) Table 45. Global Nitinol-based Medical Device Sales Market Share by Region (2021-2026) Table 46. Global Nitinol-based Medical Device Sales by Region (2027-2032) & (K Units) Table 47. Global Nitinol-based Medical Device Sales Market Share by Region (2027-2032) Table 48. Global Nitinol-based Medical Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Nitinol-based Medical Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Nitinol-based Medical Device Sales Value Share by Region (2021-2026) Table 51. Global Nitinol-based Medical Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Nitinol-based Medical Device Sales Value Share by Region (2027-2032) Table 53. Global Nitinol-based Medical Device Market Average Price (USD/Unit) by Region (2021-2026) Table 54. Global Nitinol-based Medical Device Market Average Price (USD/Unit) by Region (2027-2032) Table 55. Global Nitinol-based Medical Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Nitinol-based Medical Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Nitinol-based Medical Device Sales by Country (2021-2026) & (K Units) Table 58. Global Nitinol-based Medical Device Sales Market Share by Country (2021-2026) Table 59. Global Nitinol-based Medical Device Sales by Country (2027-2032) & (K Units) Table 60. Global Nitinol-based Medical Device Sales Market Share by Country (2027-2032) Table 61. Global Nitinol-based Medical Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Nitinol-based Medical Device Sales Value Market Share by Country (2021-2026) Table 63. Global Nitinol-based Medical Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Nitinol-based Medical Device Sales Value Market Share by Country (2027-2032) Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 68. Medtronic Nitinol-based Medical Device Product Portfolio Table 69. Medtronic Recent Development Table 70. Edwards Lifesciences Company Information Table 71. Edwards Lifesciences Business Overview Table 72. Edwards Lifesciences Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 73. Edwards Lifesciences Nitinol-based Medical Device Product Portfolio Table 74. Edwards Lifesciences Recent Development Table 75. Abbott Company Information Table 76. Abbott Business Overview Table 77. Abbott Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 78. Abbott Nitinol-based Medical Device Product Portfolio Table 79. Abbott Recent Development Table 80. Boston Scientific Company Information Table 81. Boston Scientific Business Overview Table 82. Boston Scientific Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 83. Boston Scientific Nitinol-based Medical Device Product Portfolio Table 84. Boston Scientific Recent Development Table 85. TERUMO Company Information Table 86. TERUMO Business Overview Table 87. TERUMO Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. TERUMO Nitinol-based Medical Device Product Portfolio Table 89. TERUMO Recent Development Table 90. BD Company Information Table 91. BD Business Overview Table 92. BD Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. BD Nitinol-based Medical Device Product Portfolio Table 94. BD Recent Development Table 95. Cordis Company Information Table 96. Cordis Business Overview Table 97. Cordis Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Cordis Nitinol-based Medical Device Product Portfolio Table 99. Cordis Recent Development Table 100. Cook Medical Company Information Table 101. Cook Medical Business Overview Table 102. Cook Medical Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Cook Medical Nitinol-based Medical Device Product Portfolio Table 104. Cook Medical Recent Development Table 105. B. Braun Company Information Table 106. B. Braun Business Overview Table 107. B. Braun Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. B. Braun Nitinol-based Medical Device Product Portfolio Table 109. B. Braun Recent Development Table 110. Biotronik Company Information Table 111. Biotronik Business Overview Table 112. Biotronik Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Biotronik Nitinol-based Medical Device Product Portfolio Table 114. Biotronik Recent Development Table 115. Stryker Company Information Table 116. Stryker Business Overview Table 117. Stryker Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Stryker Nitinol-based Medical Device Product Portfolio Table 119. Stryker Recent Development Table 120. JOTEC Company Information Table 121. JOTEC Business Overview Table 122. JOTEC Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. JOTEC Nitinol-based Medical Device Product Portfolio Table 124. JOTEC Recent Development Table 125. MicroPort Company Information Table 126. MicroPort Business Overview Table 127. MicroPort Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. MicroPort Nitinol-based Medical Device Product Portfolio Table 129. MicroPort Recent Development Table 130. Acandis Company Information Table 131. Acandis Business Overview Table 132. Acandis Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Acandis Nitinol-based Medical Device Product Portfolio Table 134. Acandis Recent Development Table 135. ELLA-CS Company Information Table 136. ELLA-CS Business Overview Table 137. ELLA-CS Nitinol-based Medical Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. ELLA-CS Nitinol-based Medical Device Product Portfolio Table 139. ELLA-CS Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Nitinol-based Medical Device Distributors List Table 143. Nitinol-based Medical Device Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Nitinol-based Medical Device Product Image Figure 2. Global Nitinol-based Medical Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nitinol-based Medical Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nitinol-based Medical Device Sales (2021-2032) & (K Units) Figure 5. Global Nitinol-based Medical Device Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Nitinol-based Medical Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Stents Image Figure 10. Guidewires Image Figure 11. Others Image Figure 12. Global Nitinol-based Medical Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Nitinol-based Medical Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nitinol-based Medical Device Sales Volume Share by Type (2021-2032) Figure 15. Global Nitinol-based Medical Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nitinol-based Medical Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nitinol-based Medical Device Sales Value Share by Type (2021-2032) Figure 18. Vascular Image Figure 19. Orthopedic and Dental Image Figure 20. Others Image Figure 21. Global Nitinol-based Medical Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Nitinol-based Medical Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Nitinol-based Medical Device Sales Volume Share by Application (2021-2032) Figure 24. Global Nitinol-based Medical Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Nitinol-based Medical Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Nitinol-based Medical Device Sales Value Share by Application (2021-2032) Figure 27. Global Nitinol-based Medical Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Nitinol-based Medical Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Nitinol-based Medical Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Nitinol-based Medical Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Nitinol-based Medical Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Nitinol-based Medical Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Nitinol-based Medical Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Nitinol-based Medical Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Nitinol-based Medical Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Nitinol-based Medical Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Nitinol-based Medical Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Nitinol-based Medical Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Nitinol-based Medical Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Nitinol-based Medical Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Nitinol-based Medical Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Nitinol-based Medical Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Nitinol-based Medical Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Stents
  • Guidewires
  • Others
Applications
  • Vascular
  • Orthopedic and Dental
  • Others
Companies covered
  • Medtronic
  • Edwards Lifesciences
  • Abbott
  • Boston Scientific
  • TERUMO
  • BD
  • Cordis
  • Cook Medical
  • B. Braun
  • Biotronik
  • Stryker
  • JOTEC
  • MicroPort
  • Acandis
  • ELLA-CS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nitinol-based Medical Device Sales Value (2021-2032)
  4. 1.2.2 Global Nitinol-based Medical Device Sales Volume (2021-2032)
  5. 1.2.3 Global Nitinol-based Medical Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nitinol-based Medical Device Market Dynamics
  1. 2.1 Nitinol-based Medical Device Industry Trends
  2. 2.2 Nitinol-based Medical Device Industry Drivers
  3. 2.3 Nitinol-based Medical Device Industry Opportunities and Challenges
  4. 2.4 Nitinol-based Medical Device Industry Restraints
3 Nitinol-based Medical Device Market by Company
  1. 3.1 Global Nitinol-based Medical Device Company Revenue Ranking in 2025
  2. 3.2 Global Nitinol-based Medical Device Revenue by Company (2021-2026)
  3. 3.3 Global Nitinol-based Medical Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Nitinol-based Medical Device Average Price by Company (2021-2026)
  5. 3.5 Global Nitinol-based Medical Device Company Ranking (2024-2026)
  6. 3.6 Global Nitinol-based Medical Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Nitinol-based Medical Device Company Product Type and Application
  8. 3.8 Global Nitinol-based Medical Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nitinol-based Medical Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nitinol-based Medical Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nitinol-based Medical Device Market by Type
  1. 4.1 Nitinol-based Medical Device Type Introduction
  2. 4.1.1 Stents
  3. 4.1.2 Guidewires
  4. 4.1.3 Others
  5. 4.2 Global Nitinol-based Medical Device Sales Volume by Type
  6. 4.2.1 Global Nitinol-based Medical Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nitinol-based Medical Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nitinol-based Medical Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nitinol-based Medical Device Sales Value by Type
  10. 4.3.1 Global Nitinol-based Medical Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nitinol-based Medical Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nitinol-based Medical Device Sales Value Share by Type (2021-2032)
5 Nitinol-based Medical Device Market by Application
  1. 5.1 Nitinol-based Medical Device Application Introduction
  2. 5.1.1 Vascular
  3. 5.1.2 Orthopedic and Dental
  4. 5.1.3 Others
  5. 5.2 Global Nitinol-based Medical Device Sales Volume by Application
  6. 5.2.1 Global Nitinol-based Medical Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nitinol-based Medical Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nitinol-based Medical Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nitinol-based Medical Device Sales Value by Application
  10. 5.3.1 Global Nitinol-based Medical Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nitinol-based Medical Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nitinol-based Medical Device Sales Value Share by Application (2021-2032)
6 Nitinol-based Medical Device Regional Sales and Value Analysis
  1. 6.1 Global Nitinol-based Medical Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nitinol-based Medical Device Sales by Region (2021-2032)
  3. 6.2.1 Global Nitinol-based Medical Device Sales by Region: 2021-2026
  4. 6.2.2 Global Nitinol-based Medical Device Sales by Region (2027-2032)
  5. 6.3 Global Nitinol-based Medical Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nitinol-based Medical Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nitinol-based Medical Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nitinol-based Medical Device Sales Value by Region (2027-2032)
  9. 6.5 Global Nitinol-based Medical Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nitinol-based Medical Device Sales Value (2021-2032)
  12. 6.6.2 North America Nitinol-based Medical Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nitinol-based Medical Device Sales Value (2021-2032)
  15. 6.7.2 Europe Nitinol-based Medical Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nitinol-based Medical Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nitinol-based Medical Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nitinol-based Medical Device Sales Value (2021-2032)
  21. 6.9.2 South America Nitinol-based Medical Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nitinol-based Medical Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nitinol-based Medical Device Sales Value Share by Country, 2025 VS 2032
7 Nitinol-based Medical Device Country-level Sales and Value Analysis
  1. 7.1 Global Nitinol-based Medical Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nitinol-based Medical Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nitinol-based Medical Device Sales by Country (2021-2032)
  4. 7.3.1 Global Nitinol-based Medical Device Sales by Country (2021-2026)
  5. 7.3.2 Global Nitinol-based Medical Device Sales by Country (2027-2032)
  6. 7.4 Global Nitinol-based Medical Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nitinol-based Medical Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nitinol-based Medical Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nitinol-based Medical Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nitinol-based Medical Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nitinol-based Medical Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Nitinol-based Medical Device Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Edwards Lifesciences
  8. 8.2.1 Edwards Lifesciences Company Information
  9. 8.2.2 Edwards Lifesciences Business Overview
  10. 8.2.3 Edwards Lifesciences Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Edwards Lifesciences Nitinol-based Medical Device Product Portfolio
  12. 8.2.5 Edwards Lifesciences Recent Developments
  13. 8.3 Abbott
  14. 8.3.1 Abbott Company Information
  15. 8.3.2 Abbott Business Overview
  16. 8.3.3 Abbott Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Abbott Nitinol-based Medical Device Product Portfolio
  18. 8.3.5 Abbott Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Nitinol-based Medical Device Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 TERUMO
  26. 8.5.1 TERUMO Company Information
  27. 8.5.2 TERUMO Business Overview
  28. 8.5.3 TERUMO Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TERUMO Nitinol-based Medical Device Product Portfolio
  30. 8.5.5 TERUMO Recent Developments
  31. 8.6 BD
  32. 8.6.1 BD Company Information
  33. 8.6.2 BD Business Overview
  34. 8.6.3 BD Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BD Nitinol-based Medical Device Product Portfolio
  36. 8.6.5 BD Recent Developments
  37. 8.7 Cordis
  38. 8.7.1 Cordis Company Information
  39. 8.7.2 Cordis Business Overview
  40. 8.7.3 Cordis Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cordis Nitinol-based Medical Device Product Portfolio
  42. 8.7.5 Cordis Recent Developments
  43. 8.8 Cook Medical
  44. 8.8.1 Cook Medical Company Information
  45. 8.8.2 Cook Medical Business Overview
  46. 8.8.3 Cook Medical Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cook Medical Nitinol-based Medical Device Product Portfolio
  48. 8.8.5 Cook Medical Recent Developments
  49. 8.9 B. Braun
  50. 8.9.1 B. Braun Company Information
  51. 8.9.2 B. Braun Business Overview
  52. 8.9.3 B. Braun Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 B. Braun Nitinol-based Medical Device Product Portfolio
  54. 8.9.5 B. Braun Recent Developments
  55. 8.10 Biotronik
  56. 8.10.1 Biotronik Company Information
  57. 8.10.2 Biotronik Business Overview
  58. 8.10.3 Biotronik Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Biotronik Nitinol-based Medical Device Product Portfolio
  60. 8.10.5 Biotronik Recent Developments
  61. 8.11 Stryker
  62. 8.11.1 Stryker Company Information
  63. 8.11.2 Stryker Business Overview
  64. 8.11.3 Stryker Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Stryker Nitinol-based Medical Device Product Portfolio
  66. 8.11.5 Stryker Recent Developments
  67. 8.12 JOTEC
  68. 8.12.1 JOTEC Company Information
  69. 8.12.2 JOTEC Business Overview
  70. 8.12.3 JOTEC Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 JOTEC Nitinol-based Medical Device Product Portfolio
  72. 8.12.5 JOTEC Recent Developments
  73. 8.13 MicroPort
  74. 8.13.1 MicroPort Company Information
  75. 8.13.2 MicroPort Business Overview
  76. 8.13.3 MicroPort Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 MicroPort Nitinol-based Medical Device Product Portfolio
  78. 8.13.5 MicroPort Recent Developments
  79. 8.14 Acandis
  80. 8.14.1 Acandis Company Information
  81. 8.14.2 Acandis Business Overview
  82. 8.14.3 Acandis Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Acandis Nitinol-based Medical Device Product Portfolio
  84. 8.14.5 Acandis Recent Developments
  85. 8.15 ELLA-CS
  86. 8.15.1 ELLA-CS Company Information
  87. 8.15.2 ELLA-CS Business Overview
  88. 8.15.3 ELLA-CS Nitinol-based Medical Device Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 ELLA-CS Nitinol-based Medical Device Product Portfolio
  90. 8.15.5 ELLA-CS Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nitinol-based Medical Device Value Chain Analysis
  2. 9.1.1 Nitinol-based Medical Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nitinol-based Medical Device Sales Mode & Process
  6. 9.2 Nitinol-based Medical Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nitinol-based Medical Device Distributors
  9. 9.2.3 Nitinol-based Medical Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst